Abstract:Purpose: Obesity has been implicated in the etiology of benign and malignant prostatic growth due to its influence on metabolic and endocrine changes. Because obesity is an important determinant of serum levels of insulin and leptin (the product of the obesity gene Ob), we investigated the role of obesity and serum levels of insulin and leptin in benign prostatic hyperplasia (BPH) etiology. Materials and Methods: Fasting serum levels of insulin and leptin as well as the body mass index, a measure of overall obesity, and waist-to-hip ratio, an indicator of abdominal obesity, were determined in 200 men newly diagnosed with BPH who were hospitalized for surgery and in 302 randomly selected healthy male subjects from the population in Shanghai, China. Results: A higher waist-to-hip ratio and higher serum insulin were significantly associated with an increased risk of BPH. Relative to men in the lowest waist-to-hip ratio quartile (less than 0.856) those in the highest quartile (greater than 0.923) were at 2.4-fold risk (odds ratio 2.42, 95% confidence interval [CI] 1.34 to 4.37, test for trend p = 0.01). Similarly relative to men in the lowest quartile of insulin (less than 5.87 muU. per ml.) those in the highest quartile (greater than 9.76 muU. per ml.) were at significantly increased risk (odds ratio 2.47, 95% CI 1.35 to 4.54, test for trend p = 0.009). The effect of insulin on BPH risk was more pronounced in men in low and middle tertiles of the waist-to-hip ratio (odds ratios comparing high to low insulin tertiles 2.8 and 2.7, respectively), while among men in the highest waist-to-hip ratio tertile insulin was not significantly associated with BPH risk. In contrast, we found no significant odds ratio comparing the highest to lowest quartiles of leptin (odds ratio 0.62, 95% CI 0.33 to 1.17) or body mass index (odds ratio 1.64, 95% CI 0.96 to 2.81). Conclusions: Our results suggest that abdominal obesity and increasing serum insulin, and possibly overall obesity but not serum leptin are associated with a higher risk of BPH. Further prospective and laboratory studies are needed to confirm these results and elucidate the underlying mechanisms.

Obesity and benign prostatic enlargement: a large observational study in China.

Body mass index and risk of BPH: a meta-analysis

Independent and Joint Associations of General and Abdominal Obesity with the Risk of Conventional Adenomas and Serrated Polyps: A Large Population‐based Study in East Asia

Body Size and Serum Levels of Insulin and Leptin in Relation to the Risk of Benign Prostatic Hyperplasia.

Body size and prostate cancer: a population-based case-control study in China.

[Relationship Between Serum Prostate-Specific Antigen Levels and Body Mass Index in Beijing Men over 50 Years of Age].

Higher Body Mass Index Increases the Risk for Biopsy-Mediated Detection of Prostate Cancer in Chinese Men.

The Association Between Body Mass Index and Testosterone Deficiency in Aging Chinese Men with Benign Prostatic Hyperplasia: Results from a Cross-Sectional Study

BMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people

The causal relationship between sarcopenic obesity factors and benign prostate hyperplasia

Benign prostatic hyperplasia and cardiovascular risk: a prospective study among Chinese men

Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study

[Correlation Analysis of Prostate Volume with Body Mass Index, Blood Pressure, Blood Lipid and Glucose in 30-50 Year-Old Men].

Influence of obesity on localized prostate cancer patients treated with radical prostatectomy.

Relationship Between Serum Sex Hormones Levels and Degree of Benign Prostate Hyperplasia in Chinese Aging Men

Correlation of Prostatic Morphological Parameters and Clinical Progression in Aging Chinese Men with Benign Prostatic Hyperplasia: Results from a Cross-Sectional Study.

Untargeted metabolomics reveals that declined PE and PC in obesity may be associated with prostate hyperplasia

Periodontal disease and risk of benign prostate hyperplasia: a cross-sectional study

Metabolically healthy obesity is associated with increased risk of lower urinary tract symptoms secondary to benign prostatic hyperplasia: A cohort study of Chinese elderly males

The Correlation Between Metabolic Syndrome and Benign Prostatic Hyperplasia in Men over 50 Years O1d

The relationship between body mass index and the level of serum prostate-specific antigen in 15 830 adult males in Xi'an